Who has invested in Amphista Therapeutics?

Advent Life Sciences, Scottish Investment Bank, Scottish Growth Scheme, European Investment Fund, BioMotiv are named among the investors backing Amphista Therapeutics.

Amphista Therapeutics Funding: $61M Raised, Series B

Amphista Therapeutics funding overview

Amphista Therapeutics is based in Cambridge, England. Amphista Therapeutics has raised $61M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B. Investors on record include Advent Life Sciences, Scottish Investment Bank, Scottish Growth Scheme, European Investment Fund, BioMotiv. 5 distinct backers are named across the disclosed rounds.

Amphista Therapeutics at a glance

Total raised: $61M
Latest round: Series B
Headquarters: Cambridge, England
Notable investors: Advent Life Sciences, Scottish Investment Bank, Scottish Growth Scheme, European Investment Fund, BioMotiv

Frequently asked about Amphista Therapeutics funding

How much has Amphista Therapeutics raised?: Amphista Therapeutics has raised $61M in total disclosed funding across the rounds on record.
Who has invested in Amphista Therapeutics?: Advent Life Sciences, Scottish Investment Bank, Scottish Growth Scheme, European Investment Fund, BioMotiv are named among the investors backing Amphista Therapeutics.
What was the latest Amphista Therapeutics funding round?: The most recent disclosed round is a Series B.
Where is Amphista Therapeutics based?: Amphista Therapeutics is based in Cambridge, England.

Amphista Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.

Amphista Therapeutics Funding: $61M Raised, Series B

Amphista Therapeutics funding overview

Amphista Therapeutics at a glance

Frequently asked about Amphista Therapeutics funding

Companies related to Amphista Therapeutics (35)

Browse related funding lists (5)